Becton Dickinson & Co (NYSE:BDX)
$ 235.67 0.67 (0.29%) Market Cap: 68.11 Bil Enterprise Value: 82.95 Bil PE Ratio: 51.91 PB Ratio: 2.65 GF Score: 80/100

Becton Dickinson and Co at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 08, 2021 / 12:50PM GMT
Release Date Price: $233.25 (-0.13%)
Amit Hazan
Goldman Sachs Group, Inc., Research Division - Equity Analyst

I always enjoy reading your reports, though, by the way. I think you always nail it. All right. And we are back at the 42nd Annual Goldman Sachs Healthcare Conference day 1. And we're really excited to have us as our next presenting company, Becton, Dickinson. We've got the team here, the all-star team from BD. We've got Tom Polen, the Chief Executive Officer; Chris Reidy, CFO; and Kristen Stewart, Head of IR.

And I'll turn it over to Kristen to say a couple of words, and then we will get started. Go ahead, Kristen.

Kristen Marie Stewart
Becton, Dickinson and Company - SVP of Strategy & IR

Thanks so much. So thanks for having us here. Just as a reminder, during today's discussion, we may make some forward-looking statements, and it's possible that actual results could differ from our expectations.

There continues to be significant uncertainty around the duration and contemplated impact of the COVID-19 pandemic. Risks, uncertainties and other factors that could

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot